Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects
Human Molecular Genetics · 04.05.2024 · 33 (10) · 894-904
DOI: 10.1093/hmg/ddae027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 03.03.2024. Verfasst von Alba Kaci und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Haukelandsbakken 1, Bergen 5020, Norway. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Promoter Regions, Genetic, Transcriptional Activation, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Diabetes Association, Western Norway University of Applied Sciences, Research Council of Norway.
Abstract (Originalsprache)
Hepatocyte nuclear factor-4 alpha (HNF-4A) regulates genes with roles in glucose metabolism and β-cell development. Although pathogenic HNF4A variants are commonly associated with maturity-onset diabetes of the young (MODY1; HNF4A-MODY), rare phenotypes also include hyperinsulinemic hypoglycemia, renal Fanconi syndrome and liver disease. While the association of rare functionally damaging HNF1A variants with HNF1A-MODY and type 2 diabetes is well established owing to robust functional assays, the impact of HNF4A variants on HNF-4A transactivation in tissues including the liver and kidney is less known, due to lack of similar assays. Our aim was to investigate the functional effects of seven HNF4A variants, located in the HNF-4A DNA binding domain and associated with different clinical phenotypes, by various functional assays and cell lines (transactivation, DNA binding, protein expression, nuclear localization) and in silico protein structure analyses. Variants R85W, S87N and R89W demonstrated reduced DNA binding to the consensus HNF-4A binding elements in the HNF1A promoter (35, 13 and 9%, respectively) and the G6PC promoter (R85W ~10%). While reduced transactivation on the G6PC promoter in HepG2 cells was shown for S87N (33%), R89W (65%) and R136W (35%), increased transactivation by R85W and R85Q was confirmed using several combinations of target promoters and cell lines. R89W showed reduced nuclear levels. In silico analyses supported variant induced structural impact. Our study indicates that cell line specific functional investigations are important to better understand HNF4A-MODY genotype–phenotype correlations, as our data supports ACMG/AMP interpretations of loss-of-function variants and propose assay-specific HNF4A control variants for future functional investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Haukelandsbakken 1, Bergen 5020, Norway.
- Center for Laboratory Medicine, Østfold Hospital Trust, Kalnesveien 300, Grålum 1714, Norway.
- Department of Safety, Chemistry, and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Inndalsveien 28, Bergen 5020, Norway.
- Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Jonas Lies veg 87, Bergen 5021, Norway.
- Department of Medical Genetics, Haukeland University Hospital, Jonas Lies veg 87, Bergen 5021, Norway.
- Department of Clinical Science, University of Bergen, Jonas Lies veg 87, Bergen 5020, Norway.
ORCID-Profile: Richard Caswell, Lise Bjørkhaug
Förderung
- Norwegian Diabetes Association
- Western Norway University of Applied Sciences
- Research Council of Norway
- Western Norway Regional Health Authority
- European Research Council
Zitieren
APA
Kaci, A., Solheim, M. H., Silgjerd, T., Hjaltadottir, J., Hornnes, L. H., Molnes, J., Madsen, A., Sjøholt, G., Bellanné-Chantelot, C., Caswell, R., Sagen, J. V., Njølstad, P. R., Aukrust, I., & Bjørkhaug, L. (2024). Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects. Human Molecular Genetics, 33(10), 894-904. https://doi.org/10.1093/hmg/ddae027
Vancouver
Kaci A, Solheim MH, Silgjerd T, Hjaltadottir J, Hornnes LH, Molnes J, et al. Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects. Human Molecular Genetics. 2024;33(10):894-904. doi:10.1093/hmg/ddae027
BibTeX
@article{Kaci2024,
author = {Kaci, Alba and Solheim, Marie Holm and Silgjerd, Trine and Hjaltadottir, Jorunn and Hornnes, Lorentze Hope and Molnes, Janne and Madsen, Andre and Sjøholt, Gry and Bellanné-Chantelot, Christine and Caswell, Richard and Sagen, Jørn V and Njølstad, Pål R and Aukrust, Ingvild and Bjørkhaug, Lise},
title = {Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects},
journal = {Human Molecular Genetics},
year = {2024},
volume = {33},
number = {10},
pages = {894--904},
doi = {10.1093/hmg/ddae027}
}
EUVIMED